Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Race Oncology launches two clinical programs for RC220 targeting acute myeloid leukemia and EGFR-mutated lung cancer.

flag Race Oncology has launched two new clinical programs for its drug RC220, targeting acute myeloid leukemia and EGFR-mutated lung cancer, based on new insights into its mechanism that may streamline regulatory approval. flag The moves expand the company’s pipeline into high-need cancer areas where treatment resistance is common. flag Recce Pharmaceuticals announced the passing of its founder, Dr Graham JH Melrose, a key figure in developing its anti-infective technology platform. flag Meanwhile, AuMEGA Metals began diamond drilling at its Cape Ray gold project in Canada, targeting a major airborne EM anomaly along the country’s largest known gold structure. flag Lindian Resources appointed Robert Rickie as commercial and supply manager for its Malawi rare earths project, and Terrain Minerals is preparing a 4,500-meter drilling campaign at its Lightning gold prospect in Western Australia.

10 Articles